Cognitive Behavioral and Faith Fellowship to Improve Thy Health (CB-FAITH) for Depression
This study is testing a new behavioral program called Cognitive Behavioral Faith Fellowship to Improve Thy Health (CB-FAITH) to see if it can help reduce symptoms of depression in African American adults. This program combines cognitive behavioral therapy (a type of talk therapy), Afrocentric (African-centered) ideas, and faith-based principles. Researchers will measure your depression symptoms using questionnaires like the Patient Health Questionnaire and the Quick Inventory of Depressive Symptomatology-clinician rated (QIDS-CR) at the start, during the program, and for up to 6 months afterward. You may be able to join if you are an African American man or woman, aged 18 or older, and have symptoms of major depressive disorder. The study aims to enroll 50 people in Wisconsin.
- Study design
- This study uses a randomized stepped wedge design, where church groups (clusters of 10 participants) are randomly chosen to start the CB-FAITH treatment at different times, with all groups eventually receiving the treatment. The study plans to enroll 50 participants.
- What's involved
- You would participate in the CB-FAITH intervention, and your depression symptoms would be measured at baseline, weeks 6 and 12 during the intervention, and at 3 and 6 months after the intervention.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed up for 3 and 6 months after the intervention ends.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Cognitive Behavioral and Faith Fellowship to Improve Thy Health
At a glance
Conditions
NCT06292637
Where you'd take part
This study runs at 3 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Second Baptist Church
Madison, Wisconsinstudy coordinator listed
Recruiting
University of Wisconsin - Madison
Madison, Wisconsinstudy coordinator listed
Recruiting
The Board of Regents of the UW System
Madison, Wisconsinno site contact published
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Earlise Ward, PhD · PRINCIPAL_INVESTIGATOR · University of Wisconsin, Madison
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Patient Health Questionnairebaseline, weeks 6 and 12 during the intervention, and follow up at 3 and 6 months
Patient Health Questionnaire-9 (PHQ-9) is a self-administered depression scale (5 minute completion time), which scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day). Categories of depression symptoms are defined as none (score 0-4), mild (score 5-9), moderate (score 10-14), moderately severe (score 15-19), and severe (score ≥20). In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity.
- Score on Quick Inventory of Depressive Symptomatology-clinician rated (QIDS-CR)baseline, weeks 6 and 12 during the intervention, and follow up at 3 and 6 months
The 16-item Quick Inventory of Depressive Symptomatology (QIDS) assesses depressive symptom severity and symptom change. Investigators will use the clinician rated QIDS-CR. Scores range from 0-27 and higher scores suggest higher severity of depression.